Amgen to Buy Micromet for $1.16 Billion – New York Times

January 26, 2012 Posted By: Leave a comment
Amgen has agreed to buy Micromet, a biotechnology company that develops cancer drugs ... Amgen was advised by Moelis & Company and the law firm of Sullivan & Cromwell. Goldman Sachs and the law firm of Cooley advised Micromet.
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>